Prostat Kanseri için Tedavi ve Taramayı Yönlendirecek Genetik Bilgi, GIFTS Çalışması

Sade dilde özet

Bu çalışma, prostat kanseri (prostate cancer) tanısı olan erkeklerde tedavi ve taramayı yönlendirmek amacıyla genetik testler ve genetik danışmanlık kullanarak genetik bilgiyi değerlendirmektedir. Çalışmaya, prostat kanseri tanısı almış, tükürük örneği verebilen 35-89 yaş arası erkekler ile aile üyeleri alınmaktadır. Faz uygulanmayan bir çalışma olarak yürütülmekte ve davetle katılım almaktadır.

Yukarıdaki özet, resmî kaydın sade dile aktarılmış halidir. Orijinal İngilizce başlık referans için gösterilir.

Deney bilgileri

Faz

N/A

Durum

Davetle katılım

Sponsor

Fred Hutchinson Cancer Center

Müdahale

Questionnaire, Biospecimen Collection, Genetic Testing, Genetic Counseling, Laboratory Biomarker Analysis

Başlangıç

30.11.2018

Tahmini bitiş

31.08.2028

Ülkeler

United States

İlgili genler

Merkezler

• Seattle, United States

Uygunluk kriterleri

Kriterler ClinicalTrials.gov kaydından orijinal İngilizce haliyle alınmıştır. Uygunluk kararını yalnızca deneyi yürüten ekip verebilir.

Inclusion Criteria: Case Ascertainment \[Cancer Surveillance System (CSS)/Washington State Cancer Registry (WSCR)\]:

* Signed informed consent form providing agreement for germline genetic and molecular testing, use release of health and research information; and
* Male aged 35 to 89 years; and
* Diagnosis of prostate cancer; and
* Resident of Washington state at diagnosis; and
* Willing to complete a questionnaire (online or on paper) to provide basic demographic information, family cancer history, and health history; and
* Willing and able to provide a saliva sample; and
* United States (U.S.) mailing address.

Inclusion Criteria: Case Ascertainment \[UW Medical Center (UWMC)/UW Harborview Medical Center (UWHMC)\]:

* Signed informed consent form providing agreement for germline genetic and molecular testing, use release of health and research information; and
* Male aged 35 to 89 years; and
* Diagnosis of prostate cancer; and
* Self-identifies as Black, African American, or African; and
* Receiving care at UWMC or UWHMC; and
* Willing and able to provide a saliva sample; and
* Able to provide either a U.S. mailing address or Email address or Phone number.

Inclusion Criteria: Family Recruitment

* Signed informed consent form providing agreement for germline genetic and molecular testing, use and release of health and research information; and
* Males aged 35 to 89 years; and
* Willingness to complete a questionnaire (online or on paper) to provide basic demographic information, family cancer history, and health history; and
* Willing and able to provide a saliva sample; and
* U.S. mailing address

Exclusion Criteria: Case Ascertainment

* Unable to provide informed consent, e.g., decisional impairment
* Prior bone marrow transplant
* Currently under treatment for a hematologic malignancy
* Study team members

Exclusion Criteria: Family Recruitment

* Unable to provide informed consent, e.g., decisional impairment
* Prior bone marrow transplant
* Currently under treatment for a hematologic malignancy
* Study team members